Dr. Gott: Treatment for degenerative disc disease

Dear Dr. Gott: I have recently been diagnosed with degenerative disc disease. I am 69 and also have osteoarthritis.

Study finds possible heart risk with prostate drug

Full results of a big study testing a drug for preventing prostate cancer show a higher risk of heart failure, a surprise finding that could dampen enthusiasm for expanding its use.

New Treatment Brightens Teeth, Solves Sensitivity Issues

Rob Schweizer is bleaching away a childhood insecurity. Born with cystic fibrosis, he was treated with tetracycline, which dentists say can stain teeth.

Possible Case: FDA Studying Stalevo for Risk of Prostate Cancer Risk

FDA Studying Stalevo for Risk of Prostate Cancer Risk

Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review

ROCKVILLE, Md., March 31, 2010-FDA notified healthcare
professionals and patients that it is evaluating data from a
long-term clinical trial called Stalevo Reduction in Dyskinesia
Evaluation - Parkinson’s Disease (STRIDE-PD), that may suggest…

Cubist Pharmaceuticals to End Development of CB-500,929

Decision follows review of Phase 2 top line results
LEXINGTON, Mass.–(BUSINESS WIRE)–Mar 31, 2010 -
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced
that it plans to stop investing in the clinical development of
CB-500,929…

Unauthorized Health Product, “West Pharm Therma Lean Fat Burner Energizer” May Pose Serious Health Risks

Health Canada is warning Canadians that an unauthorized health product, “West Pharm Therma Lean Fat Burner Energizer” was found on the Canadian market.

Pfizer Posts Details About Interactions With U.S. Physicians, Other Healthcare Professionals and Clinical Research Partners

First Public Disclosure to Include Payments for Clinical
Development

NEW YORK–(BUSINESS WIRE)–Mar 31, 2010 - Pfizer Inc. today
released detailed information about how and why the company works
with a range of healthcare professionals and…

Pharmalive?s Annual ?New Drug Review And Outlook? Special Report Analyzes Market Impact Of Recently Approved Medicines And Potential Blockbusters In Clinical Development

NEWTOWN, Pa., March 31, 2010 –– Canon Data Products
Group and PharmaLive.com announce the release of their annual
Special Report, New Drug Review and Outlook. This report provides
professionals working in or serving the pharmaceutical…